On Sunday, Christian Rodriguez Fornos explained in the L’Econòmic supplement of the newspaper El Punt Avui how the IPO of Mutter Ventures in Euronext Paris will be. In the interview, the CEO and Chairman of Mutter Ventures gives all the details about what this will mean for the company, especially focused on getting more liquidity…
Read more
We are really happy and proud of the sale of our invested company CS2 to Telefónica. Telefónica Group’s Telefónica Soluciones de Criptografía, S.A. has acquired Cryptography & Security Systems, S.L. (known as CS2) from its 34 shareholders. CS2 is a 100% proprietary technology with 20 years of experience, offering a comprehensive service in the…
Read more
Study shows that selection of breast cancer patients for adjuvant bisphosphonate therapy based on Inbiomotion’s MAFTEST® reduces the risk of death in comparison with current clinical guidance MAFTEST®analyses of the NSABP-B34 and AZURE landmark clinical trials confirmed clinical utility of the MAFTEST® for selection of early-stage breast cancer patients that benefit from adjuvant clodronate treatment.…
Read more
Behind the scenes of an operation that could exceed €1 billion. The MGA group, led by Marisa Guitart, was key in 2013 in driving the series B financing of Sanifit, which would end up being bought by Vifor at the end of 2021. MARISA GUITART AMECHAZURRA TEAM PIMIENTA: ANNA, JORDI, ALBERT. SITGES…
Read more
Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology • Vifor Pharma to acquire Sanifit, a clinical-stage cardio-renal biopharmaceutical company focused on treatments for progressive vascular calcification disorders, complementing and strengthening the Group’s growing nephrology portfolio • Sanifit’s lead compound, SNF472 is a novel, first-in-class inhibitor of vascular calcification in phase…
Read more Inbiomotion raises an oversubscribed financing round to launch its diagnostic product in breast cancer The financing round is led by Alta Life Sciences Spain I FCR, a vehicle managed by Altamar Private Equity SGIIC. Existing investors including Institut Català de Finances (ICF) have also participated in the financing. Inbiomotion is in advanced stage of development…
Read more